Everything a Behavioral Health Program Needs

States license behavioral health and substance use treatment programs through their own agencies, and each one defines its own levels of care, staffing rules, physical plant standards and inspection process. A program that offers outpatient, intensive outpatient and residential care may need a separate license or endorsement for each level, and each location usually needs its own. Federal rules expect the same: opioid treatment programs must comply with all applicable state laws and regulations in addition to the federal ones.

Clinicians need their own licenses as well. Counselors, social workers, psychologists, nurses and prescribers each hold a license from their own board, and your facility license usually depends on keeping qualified staff in specific roles. We prepare the facility applications, gather the policies, staffing plans and ownership documents each state asks for, work with the agency through inspection, and track every facility and clinician renewal from one record.

An opioid treatment program (OTP) needs three approvals before it can dispense methadone or other medications for opioid use disorder. Under 42 CFR Part 8, the program must hold a current certification from SAMHSA, and certification requires current accreditation by a SAMHSA-approved accreditation body. The program must also be registered with the DEA before it administers or dispenses medication, and it must comply with state law, which in practice means approval from your state's opioid treatment authority.

SAMHSA certification is granted for up to three years. A new program that has applied for accreditation can receive provisional certification for up to one year. DEA registers OTPs in their own narcotic treatment program category, which renews every year, and a separate registration is required for each location where controlled substances are dispensed.

Part 8 also sets how the program runs. Each OTP designates a program sponsor and a medical director, who is responsible for all medical and behavioral health services. Programs must offer counseling by a qualified counselor, though a patient's refusal of counseling does not keep them from medication. Initial screening can be done by telehealth when a practitioner determines an adequate evaluation is possible: buprenorphine by audio-visual or audio-only, and methadone by audio-visual unless that is not available to the patient. Take-home doses and interim treatment have their own detailed limits.

For an opioid treatment program, accreditation is not optional: SAMHSA certification depends on it, and Medicare requires both. Only accreditation bodies that SAMHSA has approved under 42 CFR Part 8 count, so we confirm the body you choose is on SAMHSA's current list. For other levels of care, whether you need accreditation depends on your state's licensing rules and on your payers' contracting requirements, and we confirm both before you choose a body.

Accreditation surveys look at the same things your state and your payers care about: written policies that match what staff actually do, clinical records that support every service, staff qualifications and training, and a working quality and safety program. We help you prepare the documents and records each standard asks for, so the survey checks work you have already done.

Programs are paid through two layers of enrollment: the program or facility itself, and the clinicians who work there. Commercial plans, Medicaid, Medicaid managed care plans and Medicare each credential separately, and some plans hand behavioral health to a separate company that runs its own network.

Medicare has paid enrolled opioid treatment programs through bundled payments for opioid use disorder treatment since January 1, 2020. To enroll, an OTP needs full SAMHSA certification, not provisional certification, and accreditation by a SAMHSA-approved body, and it applies through PECOS or on the CMS-855B. Counselors, marriage and family therapists, social workers, psychologists and prescribers who bill Medicare enroll individually and reassign their benefits to the program.

Before you sign, we review each payer contract for rates, timely filing limits, authorization rules, audit terms and termination, and compare the rates with what other payers pay for the same services. Where your volume and outcomes support it, we negotiate better rates.

Substance use disorder treatment records held by a federally assisted program are protected by 42 CFR Part 2 as well as HIPAA. HHS issued a final rule in February 2024 that brought Part 2 much closer to HIPAA. It took effect on April 16, 2024, and programs had to comply by February 16, 2026.

Under the 2024 rule, a patient can give a single consent for all future uses and disclosures of their records for treatment, payment and health care operations. A HIPAA covered entity or business associate that receives records under that consent can redisclose them as HIPAA allows, except for certain proceedings against the patient. The rule added breach notification, civil money penalties and other civil enforcement, a patient right to an accounting of disclosures made with consent and a right to request restrictions, a separate consent requirement for SUD counseling notes, and a separate consent before records are used in civil, criminal, administrative or legislative proceedings.

Our compliance program covers both rules together: a security risk assessment, written policies, consent forms that meet Part 2, the notices that go with disclosures, staff training, business associate agreements with every vendor, and a breach response plan.

Behavioral health programs bill differently from a solo practice: per diem or bundled rates for some levels of care, timed professional services for others, and authorizations that cover a set number of days or sessions. Medicare pays OTPs bundled payments for opioid use disorder treatment, a benefit that includes medication, counseling, toxicology testing and intake and periodic assessments, while Medicaid and commercial plans each set their own codes and rates for the same work.

We code from your clinical documentation, check each claim against the authorization, submit, post payments, appeal denials and follow up until each claim is paid. Utilization reviews and reauthorizations are tracked by patient so a continuing stay does not go unpaid.

Programs need records that can separate Part 2 information, track consents and authorizations by patient, and carry codes from the clinical note to the claim. Our EHR is configured for your levels of care, with intake forms and consents completed before admission and electronic prescribing, including controlled substances once your prescribers complete the DEA's identity proofing and two-factor setup.

Our telehealth platform runs HIPAA video sessions that patients join from a browser with no app to install, under a signed business associate agreement, for individual and group counseling where your state license and payers allow it. The DEA's current rules for prescribing controlled substances by telemedicine are shown in the callout here.

Opening a program, or adding a level of care, means lining up the state license, accreditation, federal approvals for an OTP, payer enrollment and staffing in the right order, because each one depends on another. We build the timeline from the steps that take longest and work through it with you.

Entity and ownership questions, real estate and local zoning are handled alongside your attorney. We cover the licensing, credentialing, compliance, EHR, telehealth and billing setup so you can open with patients able to use their coverage.